JP2002529447A5 - - Google Patents

Download PDF

Info

Publication number
JP2002529447A5
JP2002529447A5 JP2000580988A JP2000580988A JP2002529447A5 JP 2002529447 A5 JP2002529447 A5 JP 2002529447A5 JP 2000580988 A JP2000580988 A JP 2000580988A JP 2000580988 A JP2000580988 A JP 2000580988A JP 2002529447 A5 JP2002529447 A5 JP 2002529447A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
hydrogen atom
sulfonylamino
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000580988A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002529447A (ja
JP4348014B2 (ja
Filing date
Publication date
Priority claimed from DE19851184A external-priority patent/DE19851184A1/de
Application filed filed Critical
Publication of JP2002529447A publication Critical patent/JP2002529447A/ja
Publication of JP2002529447A5 publication Critical patent/JP2002529447A5/ja
Application granted granted Critical
Publication of JP4348014B2 publication Critical patent/JP4348014B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000580988A 1998-11-06 1999-10-21 N−アリールスルホニルアミノ酸オメガ−アミド Expired - Fee Related JP4348014B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19851184A DE19851184A1 (de) 1998-11-06 1998-11-06 N-Arylsulfonyl-aminosäure-omega-amide
DE19851184.1 1998-11-06
PCT/EP1999/007979 WO2000027808A1 (de) 1998-11-06 1999-10-21 N-arylsulfonyl-aminosäure-omega-amide

Publications (3)

Publication Number Publication Date
JP2002529447A JP2002529447A (ja) 2002-09-10
JP2002529447A5 true JP2002529447A5 (cg-RX-API-DMAC7.html) 2006-12-28
JP4348014B2 JP4348014B2 (ja) 2009-10-21

Family

ID=7886902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000580988A Expired - Fee Related JP4348014B2 (ja) 1998-11-06 1999-10-21 N−アリールスルホニルアミノ酸オメガ−アミド

Country Status (23)

Country Link
US (2) US6201130B1 (cg-RX-API-DMAC7.html)
EP (1) EP1124797B1 (cg-RX-API-DMAC7.html)
JP (1) JP4348014B2 (cg-RX-API-DMAC7.html)
KR (1) KR100655632B1 (cg-RX-API-DMAC7.html)
CN (1) CN1206213C (cg-RX-API-DMAC7.html)
AR (1) AR021086A1 (cg-RX-API-DMAC7.html)
AT (1) ATE260889T1 (cg-RX-API-DMAC7.html)
AU (1) AU757602B2 (cg-RX-API-DMAC7.html)
BR (1) BR9915729A (cg-RX-API-DMAC7.html)
CA (1) CA2350031C (cg-RX-API-DMAC7.html)
CZ (1) CZ302291B6 (cg-RX-API-DMAC7.html)
DE (2) DE19851184A1 (cg-RX-API-DMAC7.html)
DK (1) DK1124797T3 (cg-RX-API-DMAC7.html)
ES (1) ES2213405T3 (cg-RX-API-DMAC7.html)
HK (1) HK1041686B (cg-RX-API-DMAC7.html)
HU (1) HUP0104122A3 (cg-RX-API-DMAC7.html)
ID (1) ID28810A (cg-RX-API-DMAC7.html)
PL (1) PL198827B1 (cg-RX-API-DMAC7.html)
PT (1) PT1124797E (cg-RX-API-DMAC7.html)
RU (1) RU2228330C2 (cg-RX-API-DMAC7.html)
TR (1) TR200101245T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000027808A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200103485B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
US7071223B1 (en) * 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
MXPA05010165A (es) * 2003-04-15 2005-11-16 Warner Lambert Co Derivados de prolina biciclicos [c]-condensados y su uso para el tratamiento de estados artriticos.
EP1626962B1 (en) * 2003-05-12 2007-02-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
CN1980902A (zh) * 2004-06-29 2007-06-13 辉瑞产品有限公司 通过对羟基保护前体去保护而制备5-4-(2-羟基-丙基)-3,5-二氧代-4,5-二氢-3h-[1,2,4]三嗪-2-基-苯甲酰胺衍生物的方法
CA2572118A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
BRPI0512915A (pt) * 2004-06-29 2008-04-15 Warner Lambert Co terapias de combinação utilizando inibidores benzamida do receptor p2x7
US7576222B2 (en) 2004-12-28 2009-08-18 Wyeth Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase
MY144590A (en) 2005-07-11 2011-10-14 Wyeth Corp Glutamate aggrecanase inhibitors
KR20080058436A (ko) 2005-10-13 2008-06-25 와이어쓰 글루탐산 유도체의 제조 방법
WO2012004743A1 (en) 2010-07-09 2012-01-12 Pfizer Limited Benzenesulfonamides useful as sodium channel inhibitors
EP2953932B1 (en) * 2013-02-06 2017-03-01 Merck Patent GmbH Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1063026A1 (ru) * 1982-05-19 1990-12-07 Институт биохимии АН ЛитССР N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью
JP2764262B2 (ja) 1987-08-28 1998-06-11 持田製薬株式会社 ヒダントイン誘導体及びそれを有効成分とする医薬組成物
TW201303B (cg-RX-API-DMAC7.html) 1990-07-05 1993-03-01 Hoffmann La Roche
US5455258A (en) * 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
AU690703B2 (en) 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
EP0837901A1 (en) * 1995-06-28 1998-04-29 E.I. Du Pont De Nemours And Company Fluoropolymer nanocomposites
KR980009238A (ko) 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
CZ294063B6 (cs) * 1996-05-17 2004-09-15 Warner-Lambert Company Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem
DE19719621A1 (de) * 1997-05-09 1998-11-12 Hoechst Ag Sulfonylaminocarbonsäuren

Similar Documents

Publication Publication Date Title
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
JP5522030B2 (ja) 線維化抑制剤
JP2005500312A5 (cg-RX-API-DMAC7.html)
US20140350059A1 (en) Novel oxazolidinone derivatives
RU2005107419A (ru) Применение ингибиторов iкв-киназы при обезболивающем лечении
WO2006098918B1 (en) Substituted gamma lactams as therapeutic agents
JP2005525291A5 (cg-RX-API-DMAC7.html)
JP2004517855A5 (cg-RX-API-DMAC7.html)
CA2513092A1 (en) Compounds for the treatment of metabolic disorders
CA2446136A1 (en) Pyruvate derivatives
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
CA2529453A1 (en) Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses
MXPA05011592A (es) Compuestos para el tratamiento de trastornos metabolicos.
JPH10316662A5 (cg-RX-API-DMAC7.html)
JP2005529842A5 (cg-RX-API-DMAC7.html)
KR960701007A (ko) 피롤-아미딘계 화합물 및 약제학적으로 허용 가능한 그 염, 그 제조방법 및 상기 화합물을 포함하는 약제조성물
ATE450496T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
HUT76059A (en) New di-oxadiazole derivatives as antihyperglycemic agents and pharmaceutical compositions containing the same
RU2011121354A (ru) Синтетические миметики иммунной защиты и их применение
WO2006043655A1 (ja) 吸入用医薬組成物
ES2207108T3 (es) Derivados de acido aril carboxilico y tetrazol con un grupo de carbamoiloxi.
JP2004517151A5 (cg-RX-API-DMAC7.html)
MXPA03010867A (es) Nuevos derivados heterociclicos y uso farmaceutico de los mismos.
RU2001115706A (ru) Омега-амиды n-арилсульфонил-аминокислот
JP2002097158A5 (cg-RX-API-DMAC7.html)